In this section, you can access to the latest technical information related to the FUTURE project topic.

Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland

Background Rotaviruses (RV) are the leading cause of gastroenteritis in children less than five years of age worldwide. Rotarix®, a live attenuated monovalent vaccine containing a RV strain of G1P[8] specificity has been included in the childhood immunisation schedule from June 2013 in Scotland. This study aimed to characterise the prevalent RV strains in Scotland before and after the introduction of the RV vaccine.

» Author: Maurice G. O'Sullivan

» Reference: Vaccine, Volume 35, Issue 1

» Publication Date: 03/01/2017

» Source: ScienceDirect - GPP

« Go to Technological Watch



AIMPLAS Instituto Tecnológico del Plástico

C/ Gustave Eiffel, 4
(València Parc Tecnològic) - 46980
PATERNA (Valencia) - SPAIN

PHONE

(+34) 96 136 60 40

EMAIL

Project Management department - Sustainability and Industrial Recovery
life-future-project@aimplas.es